Product mentioned on podcasts
Avakit
by Blueprint Medicines
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
- Kate HavilandAuthor
“When Blueprint's drug Avakit showed significant mast cell depletion at just 30mg in advanced systemic mastocytosis patients — far below the 200mg cancer dose — the team recognized a chronic disease opportunity.”
Mentioned on: The Long Run with Luke Timmerman